Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.2%1-day move

₹512.55

prior close

₹509.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.8+1.7+1.6+1.3-1.2+12.6+9.2+14.1+12.3+6.5+5.7+16.7+14.1—

Up moveDown movePending

AI summary

Solara Active Pharma Sciences has notified exchanges about a change in panel member for its scheduled investor conference call on May 15, 2026 at 3:00 PM IST. One management panel member is unable to attend due to an unavoidable scheduling conflict, but the remaining panel members including MD & CEO Sandeep Rao and CFO Sarat Kumar will participate as planned. The conference call is to discuss the company's audited financial results for Q4FY26 (quarter and year ended March 31, 2026). This is a revised intimation following the original filing dated May 11, 2026, with all other details unchanged.

Likely market impact

The change is minor and procedural in nature. The investor call is proceeding as scheduled to discuss quarterly results, indicating normal corporate communication activity. Shareholders should note the dial-in details remain valid.